VectorY Therapeutics, a biotech company developing vectorized antibody approaches for the treatment of neurodegenerative diseases, has appointed Sander van Deventer, co-founder and formerly Chief Technology Officer (CTO), as CEO. Van…
VectorY Therapeutics, a biotech company developing vectorized antibody approaches for the treatment of neurodegenerative diseases, has appointed Sander van Deventer, co-founder and formerly Chief Technology Officer (CTO), as CEO. Van…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


